Ralliant (NYSE:RAL) Hits New 52-Week High – Time to Buy?

Ralliant Corporation (NYSE:RAL)’s stock price reached a new 52-week high during trading on Wednesday . The company traded as high as $56.20 and last traded at $56.1470, with a volume of 28082 shares. The stock had previously closed at $54.73.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on RAL. Citigroup upgraded Ralliant from a “neutral” rating to a “buy” rating and increased their price target for the stock from $53.00 to $61.00 in a research note on Monday, December 8th. Royal Bank Of Canada boosted their price target on shares of Ralliant from $45.00 to $52.00 and gave the company a “sector perform” rating in a research report on Friday, November 7th. Barclays raised their price objective on shares of Ralliant from $59.00 to $60.00 and gave the stock an “overweight” rating in a report on Wednesday, January 7th. Weiss Ratings reissued a “hold (c)” rating on shares of Ralliant in a report on Monday, December 29th. Finally, Oppenheimer raised their price target on Ralliant from $55.00 to $60.00 and gave the stock an “outperform” rating in a report on Monday, December 15th. Six equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Ralliant presently has an average rating of “Moderate Buy” and an average price target of $58.00.

Ralliant Stock Performance

The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.03 and a current ratio of 1.49. The stock has a market cap of $6.33 billion and a PE ratio of 44.15. The company’s 50-day moving average price is $51.78 and its two-hundred day moving average price is $46.76.

Ralliant (NYSE:RAL) last released its earnings results on Wednesday, November 5th. The company reported $0.60 earnings per share for the quarter, topping analysts’ consensus estimates of $0.58 by $0.02. The firm had revenue of $529.10 million during the quarter, compared to the consensus estimate of $519.14 million.

Ralliant Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 23rd. Stockholders of record on Monday, March 9th will be paid a $0.05 dividend. The ex-dividend date of this dividend is Monday, March 9th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.4%. Ralliant’s dividend payout ratio is 15.75%.

Institutional Trading of Ralliant

Several hedge funds have recently added to or reduced their stakes in the business. Ethic Inc. purchased a new stake in Ralliant during the fourth quarter valued at about $767,000. Sequoia Financial Advisors LLC purchased a new stake in Ralliant during the 4th quarter valued at about $215,000. Danske Bank A S purchased a new stake in Ralliant during the 4th quarter valued at about $25,000. Oppenheimer & Co. Inc. bought a new position in Ralliant during the 4th quarter worth approximately $221,000. Finally, Oppenheimer Asset Management Inc. increased its stake in Ralliant by 18.4% in the 4th quarter. Oppenheimer Asset Management Inc. now owns 10,725 shares of the company’s stock worth $546,000 after purchasing an additional 1,664 shares during the period.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.